• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒溶瘤作用:与流感病毒相关的宿主细胞抗原免疫原性增强。

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus.

作者信息

Lindenmann J, Klein P A

出版信息

J Exp Med. 1967 Jul 1;126(1):93-108. doi: 10.1084/jem.126.1.93.

DOI:10.1084/jem.126.1.93
PMID:4290961
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2138306/
Abstract

A2G mice could be solidly immunized against the Ehrlich ascites tumor by single intraperitoneal injections of homogenized and lyophilized tumor cells which had been infected with oncolytic strains of influenza A virus. Similar homogenates from noninfected tumor cells were not immunogenic, even when mixed with egg-grown virus. The immunizing principle in viral oncolysates could not be separated from the oncolytic virus by differential centrifugation or adsorption to and elution from red cells. It could be inhibited by antibody raised in rabbits against the egg-grown oncolytic virus. This reaction showed serologic specificity. Thus, the immunogenicity of an oncolysate produced with the WSA strain of neurotropic influenza virus could be inhibited by rabbit anti-WSA, but not by rabbit antibody to the TUR strain of fowl plague virus. Conversely, the immunogenicity of an oncolysate prepared with the TUR strain could be inhibited by rabbit anti-TUR, but not by anti-WSA. When mice were preimmunized (primed) with egg-grown WSA virus, their antitumor response to a later injection of WSA oncolysate was of the anamnestic type. Priming with egg-grown influenza B virus had no such effect. It was concluded that the immunogenicity of certain host cell components was greatly increased by incorporation into the makeup of the oncolytic virus.

摘要

通过单次腹腔注射经甲型流感病毒溶瘤株感染的匀浆冻干肿瘤细胞,A2G小鼠能够有效免疫抵御艾氏腹水瘤。即使与鸡胚培养的病毒混合,未感染肿瘤细胞的类似匀浆也没有免疫原性。病毒溶瘤产物中的免疫原性成分无法通过差速离心或与红细胞吸附及洗脱来与溶瘤病毒分离。它可被兔抗鸡胚培养的溶瘤病毒产生的抗体所抑制。这种反应具有血清学特异性。因此,嗜神经性流感病毒WSA株产生的溶瘤产物的免疫原性可被兔抗WSA抑制,但不能被鸡瘟病毒TUR株的兔抗体抑制。相反,TUR株制备的溶瘤产物的免疫原性可被兔抗TUR抑制,但不能被抗WSA抑制。当小鼠用鸡胚培养的WSA病毒进行预免疫(致敏)时,它们对随后注射的WSA溶瘤产物的抗肿瘤反应属于回忆反应类型。用鸡胚培养的乙型流感病毒致敏则没有这种效果。得出的结论是,某些宿主细胞成分的免疫原性通过整合到溶瘤病毒的组成中而大大增强。

相似文献

1
Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus.病毒溶瘤作用:与流感病毒相关的宿主细胞抗原免疫原性增强。
J Exp Med. 1967 Jul 1;126(1):93-108. doi: 10.1084/jem.126.1.93.
2
Host-cell antigen potentiated by incomplete growth cycle of influenza virus.由流感病毒不完全生长周期增强的宿主细胞抗原。
J Natl Cancer Inst. 1975 Feb;54(2):459-64.
3
Viral oncolysis in the A2G mouse revisited: monoclonal antibody-mediated tumor rejection.重新审视A2G小鼠中的病毒溶瘤作用:单克隆抗体介导的肿瘤排斥反应。
J Interferon Res. 1987 Oct;7(5):583-9. doi: 10.1089/jir.1987.7.583.
4
Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.用从在艾氏腹水细胞悬浮培养物中生长的流感病毒和水疱性口炎病毒制备的抗原诱导小鼠肿瘤免疫。
J Natl Cancer Inst. 1971 Jun;46(6):1161-7.
5
IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS. I. MECHANISM OF IMMUNITY TO EHRLICH ASCITES TUMOR.病毒溶瘤后对可移植肿瘤的免疫。I. 对艾氏腹水瘤的免疫机制。
J Immunol. 1964 Jun;92:912-9.
6
[Electrokinetic behavoir of Ehrlich ascites tumor cells following infection with oncolytic influenza viruses].[溶瘤性流感病毒感染后艾氏腹水瘤细胞的电动行为]
Pathol Microbiol (Basel). 1974;40(3):227-8.
7
Early events in myxovirus replication: immunofluorescent spots.黏液病毒复制的早期事件:免疫荧光斑点
Arch Virol. 1975;47(3):269-77. doi: 10.1007/BF01317814.
8
Abortive infection of influenza virus in Ehrlich ascites tumor cells. Unusual fragility of virus particles.埃利希腹水瘤细胞中流感病毒的流产感染。病毒颗粒异常脆弱。
Arch Virol. 1978;56(4):279-90. doi: 10.1007/BF01315278.
9
INEFFECTIVENESS OF ANTIBODY ON THE INTRACELLULAR DEVELOPMENT OF INFLUENZA VIRUS WS STRAIN IN EHRLICH ASCITES CELLS IN MICE.抗体对流感病毒WS株在小鼠艾氏腹水细胞内发育的无效性
J Immunol. 1964 Apr;92:648-56.
10
STUDIES ON THE TOXICITY OF INFLUENZA VIRUSES : I. THE EFFECT OF INTRACEREBRAL INJECTION OF INFLUENZA VIRUSES.流感病毒毒性研究:I. 流感病毒脑内注射的影响。
J Exp Med. 1946 Nov 30;84(6):623-37. doi: 10.1084/jem.84.6.623.

引用本文的文献

1
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application.免疫治疗胰腺癌的前沿和未来:从分子机制到临床应用。
Front Immunol. 2024 May 2;15:1383978. doi: 10.3389/fimmu.2024.1383978. eCollection 2024.
2
From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses.从威胁到治愈:对病毒诱导的细胞死亡的理解催生了高度免疫原性的溶瘤流感病毒。
Cell Death Discov. 2020 Jun 11;6:48. doi: 10.1038/s41420-020-0284-1. eCollection 2020.
3
Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives.溶瘤免疫疗法:概念演变、当前策略及未来展望
Front Immunol. 2017 May 15;8:555. doi: 10.3389/fimmu.2017.00555. eCollection 2017.
4
Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies.尝试攻克癌症;溶瘤病毒介导的抗癌疫苗接种策略
Biomedicines. 2017 Jan 4;5(1):3. doi: 10.3390/biomedicines5010003.
5
Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model.使用溶瘤腺病毒诱导免疫原性细胞死亡的全细胞疫苗对结直肠癌模型有效。
Mol Ther Oncolytics. 2016 Dec 14;3:16031. doi: 10.1038/mto.2016.31. eCollection 2016.
6
Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.免疫调节抗体疗法联合溶瘤病毒治疗癌症。
Mol Ther Oncolytics. 2014 Dec 10;1:14004. doi: 10.1038/mto.2014.4. eCollection 2014.
7
Oncolytic virus-mediated reversal of impaired tumor antigen presentation.溶瘤病毒介导的肿瘤抗原呈递受损的逆转。
Front Oncol. 2014 Apr 10;4:77. doi: 10.3389/fonc.2014.00077. eCollection 2014.
8
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.溶瘤免疫疗法:以正确方式死亡是激发强大抗肿瘤免疫力的关键。
Front Oncol. 2014 Apr 10;4:74. doi: 10.3389/fonc.2014.00074. eCollection 2014.
9
Oncolytic viruses as therapeutic cancer vaccines.溶瘤病毒作为治疗性癌症疫苗。
Mol Cancer. 2013 Sep 11;12(1):103. doi: 10.1186/1476-4598-12-103.
10
A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis.理性设计的 A34R 突变溶瘤痘病毒:改善腹膜癌转移的疗效。
Mol Ther. 2013 May;21(5):1024-33. doi: 10.1038/mt.2013.27. Epub 2013 Feb 26.

本文引用的文献

1
PRECIPITIN REACTIONS OF HIGHLY PURIFIED INFLUENZA VIRUSES AND RELATED MATERIALS.高度纯化的流感病毒及相关物质的沉淀反应。
J Exp Med. 1946 Mar 31;83(4):281-94.
2
A simple chromatographic method for preparation of gamma globulin.一种制备γ球蛋白的简易色谱法。
Proc Soc Exp Biol Med. 1960 Jan;103:250-2. doi: 10.3181/00379727-103-25476.
3
The host-tissue component of influenza viruses.流感病毒的宿主组织成分。
Proc R Soc Lond B Biol Sci. 1955 May 17;143(913):504-22. doi: 10.1098/rspb.1955.0026.
4
IMMUNITY AND ANTIBODY FORMATION INDUCED BY INTRAPERITONEAL OR SUBCUTANEOUS INJECTION OF KREBS-2 ASCITES TUMOR CELLS TREATED WITH INFLUENZA VIRUS.经流感病毒处理的克雷布斯-2腹水瘤细胞腹腔内或皮下注射诱导的免疫和抗体形成
J Natl Cancer Inst. 1965 May;34:661-72.
5
IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS.II. ANTIGENIC SIMILARITIES BETWEEN THREE UNSPECIFIC MOUSE TUMORS.病毒溶瘤后对可移植肿瘤的免疫性。II. 三种非特异性小鼠肿瘤之间的抗原相似性。
J Immunol. 1965 Mar;94:461-6.
6
HOMEOSTASIS OF ANTIBODY FORMATION IN THE ADULT RAT.成年大鼠抗体形成的稳态
J Exp Med. 1964 Dec 1;120(6):987-1005. doi: 10.1084/jem.120.6.987.
7
THE IMMUNE RESPONSE IN THE PRESENCE OF DELAYED HYPERSENSITIVITY OF CIRCULATING ANTIBODY.存在循环抗体迟发型超敏反应时的免疫应答
J Immunol. 1964 Sep;93:495-510.
8
IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS. I. MECHANISM OF IMMUNITY TO EHRLICH ASCITES TUMOR.病毒溶瘤后对可移植肿瘤的免疫。I. 对艾氏腹水瘤的免疫机制。
J Immunol. 1964 Jun;92:912-9.
9
THE RESISTANCE OF A2G MICE TO MYXOVIRUSES.A2G小鼠对黏液病毒的抵抗力。
J Immunol. 1963 Jun;90:942-51.
10
Origin of lipids in influenza virus.流感病毒中脂质的起源
Cold Spring Harb Symp Quant Biol. 1962;27:293-301. doi: 10.1101/sqb.1962.027.001.027.